[[{“value”:”
Respiratory disease and immunology are the initial focus areas of GSK’s new drug discovery partnership with Flagship Pioneering. A similar Flagship alliance with Pfizer recently announced it is pursuing novel obesity treatments.
The post GSK, Flagship Pioneering Commit $150M to Start R&D Pact for Novel Drugs and Vaccines appeared first on MedCity News.
“}]]
